Curaleaf Holdings (CURLF) EBT (2019 - 2026)

Curaleaf Holdings has reported EBT for 8 years, with the latest figure at -$26.3 million in Q2 2026.

• On a quarterly basis, EBT fell 61.4% year-over-year to -$26.3 million in Q2 2026; TTM through Jun 2026 was -$96.0 million, a 21.13% increase from a year earlier, with the FY2025 full-year figure at -$78.2 million, up 31.0% from the prior year.
• EBT was -$26.3 million for Q2 2026 at Curaleaf Holdings, up from -$28.6 million in the prior quarter.
• The five-year high for EBT was $31.9 million in Q2 2022, with the low at -$145.9 million in Q4 2022.
• Average EBT over 5 years is -$26.0 million, with a median of -$17.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: EBT jumped 224.16% in 2022, then slumped 520.56% in 2023.
• Over 5 years, EBT stood at -$145.9 million in 2022, then surged by 58.46% to -$60.6 million in 2023, then declined by 27.39% to -$77.2 million in 2024, then soared by 78.32% to -$16.7 million in 2025, then tumbled by 57.11% to -$26.3 million in 2026.
• The last three EBT figures came in at -$26.3 million (Q2 2026), -$28.6 million (Q1 2026), and -$16.7 million (Q4 2025), per Business Quant data.